AK

Anik Karan

MIT World Peace University, University of Kansas, Cl Lab LLC

Research areas: Materials Science · Biomaterials · Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine · Nanoparticle-Based Drug Delivery

ORCID iD 0000-0002-5302-8408
Follow

About

Dr. Anik Karan, Ph.D., MRSC is an Assistant Professor in the Department of Bioengineering at Dr. Vishwanath D. Karad MIT-World Peace University, Pune. His research spans across multiple fields, including biomaterials science, neuroscience, cancer biology, tissue engineering and biomedical imaging. Dr. Karan previously worked as a Postdoctoral Research Associate at the Department of Surgery and Transplant at the University of Nebraska Medical Center, Omaha, Nebraska, USA and the Department of Radiation Oncology and Department of Bioengineering at the University of Kansas Medical School and University of Kansas, contributing to studies on tissue engineering related to chronic wound healing and bone regeneration. He also has more than two years of experience in the biotechnology industry under L’Oreal, USA and Cl Lab LLC, Maryland , USA. In L’Oreal, he has worked on developing sustainable natural hair dye delivery systems through clay-based nano-carriers and in Cl Lab LLC., generating defined disease models for preclinical studies in the areas of type 2 diabetes treatment and Heart Failure with Preserved Ejection Fraction (HFpEF) treatments. He has done his Master of Science and Doctor of Philosophy in Biomedical Engineering from Louisiana Tech University, Louisiana, USA, on the topic of the development of novel biodegradable metal-organic conjugates and their applications in the areas of wound healing and cancer treatments. He has published extensively in leading Q1 journals, including Acta Biomaterialia, Materials Today Bio, Aging Research Reviews, Advanced Science and ACS Applied Nanomaterials. He serves as a review editor for several reputed Q1 journals from Elsevier, ACS, RSC, Taylor & Francis, Springer Nature, BMC, Frontiers and MDPI, including RSC Advances, RSC New Journal of Chemistry, BMC Cancer, ACS Applied Biomaterials Science and Engineering, and Springer Nature Advanced Composites and Hybrid Materials. He is a full member of the American Chemical Society (ACS), USA, Royal Society of Chemistry (RSC), UK, Sigma Xi, USA and the Biomedical Engineering Society (BMES), USA. His research area focuses on advanced therapeutic treatments for chronic wounds and bone defects using various combinatorial therapeutic modalities involving various synergistic biomaterials with various non-invasive treatment methods, such as electrical impulses and focused ultrasound.

Employment

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications

Publications are unavailable.